As for 3 studies reporting DFS, increased SIRT1 expression was also associated with poor HCC prognosis (HR=1.44, 95%CI:1.06-1.96, P=0.02) without significant heterogeneity (I2 =7%, P=0.34) (Figure 3). Here, SIRT1 is linked to hepatocellular carcinoma.